![]() |
인쇄하기
취소
|
Boryung Pharmaceutical's 'Kanarb' recorded a total of 115.5 billion won sales from its release date of March 1, 2011, to three years after the release of this year.
The profit structure of Kanarb can be divided into three types, such as ▲ domestic sales ▲ overseas sales ▲ others.
First, Kanarb recorded sales of 10 billion won in 2011, 18.2 billion won in 2012, and 21.8 billino won in 2013, an...